BSEInsider Trading / SAST23 Jun 2026 · 23 Jun 2026, 11:25 am

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Ramniklal Gosalia

Parmax Pharma Ltd · 540359

✦ AI Summary

A non-promoter shareholder, Pradeep Ramniklal Gosalia, disclosed the disposal of 3,00,000 equity shares of Parmax Pharma Ltd through an off-market transfer on June 18, 2026. This transaction reduced his holding from 8.09% (3,02,714 shares) to 0.07% (2,714 shares). This is a compliance filing under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, reporting a significant reduction in a substantial non-promoter's stake.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment4/10

Full Announcement

Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011